Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 23, 2000

View Archived Issues

Medigene, Aventis Enter Tumor Vaccine Deal Worth Up To $34M

Biovector, BioChem Pharma Align For Bacterium Vaccine

Epidauros Reports Discovery Of MDR-1 Gene Polymorphisms

Gemini Joins Genetics Effort Through Venture In Canada

CMV Research Shows NK Cells Have Role Controlling Infection

Chemunex Sees Further Gains In Acceptance Of ChemScan

MorphoSys, GPC Hit Milestone In Cancer Antibodies Program

Marketing Of Novartis' Bt Corn Blocked By German Authorities

New Debate Produces Further Delay In Framework For GMOs

Inpharmatica Identifies Target In Collaboration With Arrow

Israeli, Palestinian Scientists Unite For Research, Peace

Bavarian Nordic Moves Third Product Into Clinical Studies

Other News To Note

BTG Wins Israeli Approval For Recombinant Vaccine

Oxford Biomedica Signs 3rd Deal For Vector Technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...